What the FDA has explicitly stated: The FDA has issued warning letters to specific compounding facilities for violations including labeling errors, failure to meet sterility requirements, and use of semaglutide salt forms (sodium and acetate salts) rather than semaglutide base
[PMID: 2510729] PubMed record related to this compound for laboratory literature review
When to Seek Medical Help Contact your doctor or pharmacist if you: Notice lumps or discoloration at injection sites Experience nausea, vomiting, or dizziness Have any allergic reactions such as rash, swelling, or shortness of breath For emergencies or suspected allergic reactions, seek immediate medical attention
To our knowledge, this is the first large observational study to investigate the impact of CGM use in a large population of T2D adults treated with GLP-1
Our expert medical team has been prescribing Wegovy since it first became FDA approved to treat weight loss
The system was created during World War II to provide certain standards to the public for general health